✦ LIBER ✦

PCN9 COST COMPARISON ANALYSIS OF INTRAVENOUS VERSUS COMBINED INTRAVENOUS-ORAL CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER

✍ Scribed by A Skowron; J Brandys

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN33 COST-UTILITY ANALYSIS OF CHEMOTHER

✍ H Sakamaki; S Ikeda; S Yajima; N Ikegami; K Tanaka; J Murayama 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Five-Day Oral Etoposide2 Treatment for A

✍ Souhami, R. L.; Spiro, S. G.; Rudd, R. M.; Elvira, M.-C. R. d.; James, L. E.; Go 📂 Article 📅 1997 🏛 Oxford University Press 🌐 English ⚖ 57 KB

PCN15 COST ANALYSIS BETWEEN TYROSINE KIN

✍ Topibulpong, N; Tanasanvimon, S; Parinyanitikul, N; Sriuranpong, V 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Phase II study of prolonged oral etoposi

✍ Miller, Antonius A.; Niell, Harvey B.; Griffin, John P. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 473 KB

Phase II study of prolonged oral etoposi

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

PCN7 MAJOR DETERMINANTS OF COST IN ADVAN

✍ D Tilden; M Aristides; A Kielhorn; S Bhalla 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB